{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:39:04Z","timestamp":1790267944350,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Since December 2019, the COVID-19 pandemic has changed the concept of medicine. This work aims to analyze the use of antibiotics in patients admitted to the hospital due to SARS-CoV-2 infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This work analyzes the use and effectiveness of antibiotics in hospitalized patients with COVID-19 based on data from the SEMI-COVID-19 registry, an initiative to generate knowledge about this disease using data from electronic medical records. Our primary endpoint was all-cause in-hospital mortality according to antibiotic use. The secondary endpoint was the effect of macrolides on mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 13,932 patients, antibiotics were used in 12,238. The overall death rate was 20.7% and higher among those taking antibiotics (87.8%). Higher mortality was observed with use of all antibiotics (OR 1.40, 95% CI 1.21\u20131.62;<jats:italic>p<\/jats:italic>\u2009&lt;\u2009.001) except macrolides, which had a higher survival rate (OR 0.70, 95% CI 0.64\u20130.76;<jats:italic>p<\/jats:italic>\u2009&lt;\u2009.001). The decision to start antibiotics was influenced by presence of increased inflammatory markers and any kind of infiltrate on an x-ray. Patients receiving antibiotics required respiratory support and were transferred to intensive care units more often.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Bacterial co-infection was uncommon among COVID-19 patients, yet use of antibiotics was high. There is insufficient evidence to support widespread use of empiric antibiotics in these patients. Most may not require empiric treatment and if they do, there is promising evidence regarding azithromycin as a potential COVID-19 treatment.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12879-021-06821-1","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T17:19:45Z","timestamp":1636391985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Inadequate use of antibiotics in the covid-19 era: effectiveness of antibiotic therapy"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7705-2656","authenticated-orcid":false,"given":"Alejandro David","family":"Bendala Estrada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Calder\u00f3n Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Fern\u00e1ndez Carracedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mui\u00f1o M\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ramos Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mu\u00f1ez Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Rubio-Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Agudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Arnalich Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Estrada Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Taboada Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anxela","family":"Crestelo Vieitez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Maria","family":"Pesqueira Fontan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bustamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago J.","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Oriol-Berm\u00fadez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Artero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n","family":"Olalla Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Areses Manrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Francisco Javier","family":"Carrasco-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Carolina","family":"Vento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema Mar\u00eda","family":"Garc\u00eda Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Cubero-Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Manuel","family":"Casas-Rojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Mill\u00e1n","family":"N\u00fa\u00f1ez-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"issue":"15","key":"6821_CR1","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1093\/cid\/ciaa272","volume":"71","author":"Z Wang","year":"2020","unstructured":"Wang Z, Yang B, Li Q, et al. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020;71(15):769\u201377. https:\/\/doi.org\/10.1093\/cid\/ciaa272.","journal-title":"Clin Infect Dis"},{"key":"6821_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1001\/jama.2020.1097","volume":"323","author":"AL Phelan","year":"2020","unstructured":"Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA. 2020;323:709\u201310. https:\/\/doi.org\/10.1001\/jama.2020.1097.","journal-title":"JAMA"},{"key":"6821_CR3","doi-asserted-by":"crossref","unstructured":"World Health Organization. Coronavirus disease (COVID- 19) Situation Report. Accessed 05\/31\/2021, at https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports.","DOI":"10.47191\/ijcsrr\/V5-i8-12"},{"key":"6821_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.rce.2020.07.003","author":"JM Casas-Rojo","year":"2020","unstructured":"Casas-Rojo JM, Ant\u00f3n-Santos JM, Mill\u00e1n-N\u00fa\u00f1ez-Cort\u00e9s J, et al. Clinical characteristics of patients hospitalized with COVID-19 in Spain: results from the SEMI-COVID-19 Registry. Rev Clin Esp. 2020. https:\/\/doi.org\/10.1016\/j.rce.2020.07.003.","journal-title":"Rev Clin Esp"},{"key":"6821_CR5","unstructured":"Situaci\u00f3n de COVID-19 en Espa\u00f1a. Ministerio de Sanidad. Centro de Coordinaci\u00f3n de Alertas y Emergencias Sanitarias. 2021. Accessed 05\/31\/2021, at https:\/\/cnecovid.isciii.es\/covid19\/."},{"issue":"12","key":"6821_CR6","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.4103\/jfmpc.jfmpc_1860_20","volume":"9","author":"RK Pal","year":"2020","unstructured":"Pal RK, Naik G, Rathore V, Sahu KK, Kumar R. Comparison between two different successful approaches to COVID-19 pandemic in India (Dharavi versus Kerala). J Family Med Prim Care. 2020;9(12):5827\u201332. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_1860_20.","journal-title":"J Family Med Prim Care"},{"issue":"5","key":"6821_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-049089","volume":"11","author":"MC Castro","year":"2021","unstructured":"Castro MC, Gurzenda S, Mac\u00e1rio EM, Fran\u00e7a GVA. Characteristics, outcomes and risk factors for mortality of 522 167 patients hospitalised with COVID-19 in Brazil: a retrospective cohort study. BMJ Open. 2021;11(5): e049089. https:\/\/doi.org\/10.1136\/bmjopen-2021-049089.","journal-title":"BMJ Open"},{"issue":"2","key":"6821_CR8","doi-asserted-by":"publisher","first-page":"e00203","DOI":"10.1128\/mSphere.00203-20","volume":"5","author":"S Weston","year":"2020","unstructured":"Weston S, Frieman MB. COVID-19: knowns, unknowns, and questions. mSphere. 2020;5(2):e00203-e220. https:\/\/doi.org\/10.1128\/mSphere.00203-20.","journal-title":"mSphere"},{"key":"6821_CR9","unstructured":"Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health, 2020, https:\/\/www.covid19treatmentguidelines.nih.gov\/."},{"key":"6821_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa530","author":"TM Rawson","year":"2020","unstructured":"Rawson TM, Moore LSP, Zhu N, et al. Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa530.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"6821_CR11","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1152\/physrev.00032.2017","volume":"98","author":"LJ Quinton","year":"2018","unstructured":"Quinton LJ, Walkey AJ, Mizgerd JP. Integrative physiology of pneumonia. Physiol Rev. 2018;98(3):1417\u201364. https:\/\/doi.org\/10.1152\/physrev.00032.2017.","journal-title":"Physiol Rev"},{"issue":"Suppl3","key":"6821_CR12","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/irv.12174","volume":"7","author":"JC Deng","year":"2013","unstructured":"Deng JC. Viral-bacterial interactions-therapeutic implications. Influenza Other Respir Viruses. 2013;7(Suppl3):24\u201335. https:\/\/doi.org\/10.1111\/irv.12174.","journal-title":"Influenza Other Respir Viruses"},{"key":"6821_CR13","unstructured":"Yamada M, Suzuki H. Influenza virus pneumonia. Ryoikibetsu Shokogun Shirizu, 1999; (24 Pt 2):83\u201386."},{"issue":"9773","key":"6821_CR14","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/S0140-6736(10)61459-6","volume":"377","author":"O Ruuskanen","year":"2011","unstructured":"Ruuskanen O, Lahti E, Jennings LC, et al. Viral pneumonia. Lancet. 2011;377(9773):1264\u201375. https:\/\/doi.org\/10.1016\/S0140-6736(10)61459-6.","journal-title":"Lancet"},{"issue":"7","key":"6821_CR15","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","volume":"200","author":"JP Metlay","year":"2019","unstructured":"Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45\u201367. https:\/\/doi.org\/10.1164\/rccm.201908-1581ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"6821_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3947\/ic.2018.50.2.160","volume":"50","author":"MS Lee","year":"2018","unstructured":"Lee MS, Oh JY, Kang CI, et al. Guideline for antibiotic use in adults with community-acquired pneumonia. Infect Chemother. 2018;50(2):160\u201398. https:\/\/doi.org\/10.3947\/ic.2018.50.2.160.","journal-title":"Infect Chemother"},{"issue":"3","key":"6821_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1055\/s-0032-1315635","volume":"33","author":"C Feldman","year":"2012","unstructured":"Feldman C, Anderson R. Antibiotic resistance of pathogens causing community-acquired pneumonia. Semin Respir Crit Care Med. 2012;33(3):232\u201343. https:\/\/doi.org\/10.1055\/s-0032-1315635.","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"6821_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.idc.2016.02.004","volume":"30","author":"D Van Duin","year":"2016","unstructured":"Van Duin D, Paterson DL. Multidrug-resistant bacteria in the community: trends and lessons learned. Infect Dis Clin North Am. 2016;30(2):377\u201390. https:\/\/doi.org\/10.1016\/j.idc.2016.02.004.","journal-title":"Infect Dis Clin North Am"},{"key":"6821_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.arcmed.2020.06.004","author":"I Karampela","year":"2020","unstructured":"Karampela I, Dalamaga M. Could respiratory fluoroquinolones, levofloxacin and moxifloxacin, prove to be beneficial as an adjunct treatment in COVID-19? Arch Med Res. 2020. https:\/\/doi.org\/10.1016\/j.arcmed.2020.06.004.","journal-title":"Arch Med Res"},{"issue":"3","key":"6821_CR20","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.accpm.2020.04.005","volume":"39","author":"E Novy","year":"2020","unstructured":"Novy E, Scala-Bertola J, Roger C, et al. Preliminary therapeutic drug monitoring data of \u03b2-lactams in critically ill patients with SARS-CoV-2 infection. Anaesth Crit Care Pain Med. 2020;39(3):387\u20138. https:\/\/doi.org\/10.1016\/j.accpm.2020.04.005.","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"2","key":"6821_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106053","volume":"56","author":"A Pani","year":"2020","unstructured":"Pani A, Lauriola M, Romandini A, et al. Macrolides and viral infections: focus on azithromycin in COVID-19 pathology. Int J Antimicrob Agents. 2020;56(2): 106053. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106053.","journal-title":"Int J Antimicrob Agents"},{"key":"6821_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/649570","volume":"2012","author":"JY Min","year":"2012","unstructured":"Min JY, Jang YJ. Macrolide therapy in respiratory viral infections. Mediators Inflamm. 2012;2012: 649570. https:\/\/doi.org\/10.1155\/2012\/649570.","journal-title":"Mediators Inflamm"},{"issue":"2","key":"6821_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.5582\/bst.2020.03058","volume":"14","author":"M Ohe","year":"2020","unstructured":"Ohe M, Shida H, Jodo S, et al. Macrolide treatment for COVID-19: will this be the way forward? Biosci Trends. 2020;14(2):159\u201360. https:\/\/doi.org\/10.5582\/bst.2020.03058.","journal-title":"Biosci Trends"},{"issue":"1","key":"6821_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.4172\/1948-5964.1000173","volume":"10","author":"E Bosseboeuf","year":"2018","unstructured":"Bosseboeuf E, Aubry M, Nhan T, et al. Azithromycin Inhibits the replication of Zika virus. J Antivir Antiretrovir. 2018;10(1):6\u201311. https:\/\/doi.org\/10.4172\/1948-5964.1000173.","journal-title":"J Antivir Antiretrovir"},{"issue":"10","key":"6821_CR25","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41429-019-0204-x","volume":"72","author":"DH Tran","year":"2019","unstructured":"Tran DH, Sugamata R, Hirose T, et al. Azithromycin, a 15-membered macrolide antibiotic, inhibits influenza A(H1N1)pdm09 virus infection by interfering with virus internalization process. J Antibiot (Tokyo). 2019;72(10):759\u201368. https:\/\/doi.org\/10.1038\/s41429-019-0204-x.","journal-title":"J Antibiot (Tokyo)"},{"issue":"7","key":"6821_CR26","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.cmi.2020.04.024","volume":"26","author":"BD Huttner","year":"2020","unstructured":"Huttner BD, Catho G, Pano-Pardo JR, et al. COVID-19: don\u2019t neglect antimicrobial stewardship principles. Clin Microbiol Infect. 2020;26(7):808\u201310. https:\/\/doi.org\/10.1016\/j.cmi.2020.04.024.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"6821_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105944","volume":"55","author":"SA Baron","year":"2020","unstructured":"Baron SA, Devaux C, Colson P, et al. Teicoplanin: An alternative drug for the treatment of coronavirus COVID-19? Int J Antimicrob Agents. 2020;55(4): 105944. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105944.","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"6821_CR28","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1164\/rccm.202003-0543OC","volume":"201","author":"Y Du","year":"2020","unstructured":"Du Y, Tu L, Zhu P, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan: a retrospective observational study. Am J Respir Crit Care Med. 2020;201(11):1372\u20139. https:\/\/doi.org\/10.1164\/rccm.202003-0543OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"6821_CR29","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/S2213-2600(20)30071-0","volume":"8","author":"J Zhang","year":"2020","unstructured":"Zhang J, Zhou L, Yang Y, et al. Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics. Lancet Respir Med. 2020;8(3):e11\u20132. https:\/\/doi.org\/10.1016\/S2213-2600(20)30071-0.","journal-title":"Lancet Respir Med"},{"issue":"20","key":"6821_CR30","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1001\/jama.2020.6266","volume":"323","author":"D Kim","year":"2020","unstructured":"Kim D, Quinn J, Pinsky B, et al. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA. 2020;323(20):2085\u20136. https:\/\/doi.org\/10.1001\/jama.2020.6266.","journal-title":"JAMA"},{"issue":"18","key":"6821_CR31","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708\u201320. https:\/\/doi.org\/10.1056\/NEJMoa2002032 (Epub 2020 Feb 28).","journal-title":"N Engl J Med"},{"issue":"10229","key":"6821_CR32","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(20)30566-3.","journal-title":"Lancet"},{"issue":"15","key":"6821_CR33","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/cid\/ciaa199","volume":"71","author":"J Wu","year":"2020","unstructured":"Wu J, Liu J, Zhao X, et al. Clinical characteristics of imported cases of Coronavirus Disease 2019 (COVID-19) in Jiangsu province: a Multicenter Descriptive Study. Clin Infect Dis. 2020;71(15):706\u201312. https:\/\/doi.org\/10.1093\/cid\/ciaa199.","journal-title":"Clin Infect Dis"},{"key":"6821_CR34","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1996","volume":"369","author":"MG Argenziano","year":"2020","unstructured":"Argenziano MG, Bruce SL, Slater CL, et al. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series. BMJ. 2020;369: m1996. https:\/\/doi.org\/10.1136\/bmj.m1996.","journal-title":"BMJ"},{"issue":"6","key":"6821_CR35","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.12270","volume":"3","author":"G Suleyman","year":"2020","unstructured":"Suleyman G, Fadel RA, Malette KM, et al. Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit. JAMA Netw Open. 2020;3(6): e2012270. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.12270.","journal-title":"JAMA Netw Open"},{"key":"6821_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.07.016","author":"BJ Langford","year":"2020","unstructured":"Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.016.","journal-title":"Clin Microbiol Infect"},{"key":"6821_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa326","author":"B Beovi\u0107","year":"2020","unstructured":"Beovi\u0107 B, Dousak M, Ferreira-Coimbra J, et al. Antibiotic use in patients with COVID-19: a \u2018snapshot\u2019 Infectious Diseases International Research Initiative (ID-IRI) survey. J Antimicrob Chemother. 2020. https:\/\/doi.org\/10.1093\/jac\/dkaa326.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"6821_CR38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-020-0395-y","volume":"18","author":"TM Rawson","year":"2020","unstructured":"Rawson TM, Ming D, Ahmad R, et al. Antimicrobial use, drug-resistant infections and COVID-19. Nat Rev Microbiol. 2020;18(8):409\u201310. https:\/\/doi.org\/10.1038\/s41579-020-0395-y.","journal-title":"Nat Rev Microbiol"},{"key":"6821_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/iub.2356.10.1002\/iub.2356","author":"R Mirzaei","year":"2020","unstructured":"Mirzaei R, Goodarzi P, Asadi M, et al. Bacterial co-infections with SARS-CoV-2. IUBMB Life. 2020. https:\/\/doi.org\/10.1002\/iub.2356.10.1002\/iub.2356.","journal-title":"IUBMB Life"},{"issue":"3","key":"6821_CR40","doi-asserted-by":"publisher","first-page":"ofaa066","DOI":"10.1093\/ofid\/ofaa066","volume":"7","author":"G Abelenda-Alonso","year":"2020","unstructured":"Abelenda-Alonso G, Rombauts A, Gudiol C, et al. Influenza and bacterial coinfection in adults with community-acquired pneumonia admitted to conventional wards: risk factors, clinical features, and outcomes. Open Forum Infect Dis. 2020;7(3):ofaa066. https:\/\/doi.org\/10.1093\/ofid\/ofaa066.","journal-title":"Open Forum Infect Dis"},{"key":"6821_CR41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/82_2014_394","volume":"385","author":"AM Smith","year":"2014","unstructured":"Smith AM, McCullers JA. Secondary bacterial infections in influenza virus infection pathogenesis. Curr Top Microbiol Immunol. 2014;385:327\u201356. https:\/\/doi.org\/10.1007\/82_2014_394.","journal-title":"Curr Top Microbiol Immunol"},{"key":"6821_CR42","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3389\/fcimb.2017.00338","volume":"7","author":"L Jia","year":"2017","unstructured":"Jia L, Xie J, Zhao J, et al. Mechanisms of severe mortality-associated bacterial co-infections following influenza virus infection. Front Cell Infect Microbiol. 2017;7:338. https:\/\/doi.org\/10.3389\/fcimb.2017.00338.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"6821_CR43","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1186\/s12879-017-2858-y","volume":"17","author":"N Katsurada","year":"2017","unstructured":"Katsurada N, Suzuki M, Aoshima M, et al. The impact of virus infections on pneumonia mortality is complex in adults: a prospective multicentre observational study. BMC Infect Dis. 2017;17(1):755. https:\/\/doi.org\/10.1186\/s12879-017-2858-y.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"6821_CR44","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12879-018-3366-4","volume":"18","author":"J Quah","year":"2018","unstructured":"Quah J, Jiang B, Tan PC, et al. Impact of microbial Aetiology on mortality in severe community-acquired pneumonia. BMC Infect Dis. 2018;18(1):451. https:\/\/doi.org\/10.1186\/s12879-018-3366-4.","journal-title":"BMC Infect Dis"},{"key":"6821_CR45","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3389\/fmicb.2017.01041","volume":"8","author":"DE Morris","year":"2017","unstructured":"Morris DE, Cleary DW, Clarke SC. Secondary bacterial infec-tions associated with influenza pandemics. Front Microbiol. 2017;8:1041. https:\/\/doi.org\/10.3389\/fmicb.2017.01041.","journal-title":"Front Microbiol"},{"issue":"20","key":"6821_CR46","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1056\/NEJMoa0908481","volume":"361","author":"SA Webb","year":"2009","unstructured":"Webb SA, Pettil\u00e4 V, Seppelt I, et al. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361(20):1925\u201334. https:\/\/doi.org\/10.1056\/NEJMoa0908481.","journal-title":"N Engl J Med"},{"issue":"3","key":"6821_CR47","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jinf.2012.04.009","volume":"65","author":"C Cill\u00f3niz","year":"2012","unstructured":"Cill\u00f3niz C, Ewig S, Men\u00e9ndez R, et al. Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia. J Infect. 2012;65(3):223\u201330. https:\/\/doi.org\/10.1016\/j.jinf.2012.04.009.","journal-title":"J Infect"},{"issue":"5","key":"6821_CR48","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1097\/CCM.0b013e3182416f23","volume":"40","author":"TW Rice","year":"2012","unstructured":"Rice TW, Rubinson L, Uyeki TM, et al. Critical illness from 2009 pandemic influenza A virus and bacterial coinfection in the United States. Crit Care Med. 2012;40(5):1487\u201398. https:\/\/doi.org\/10.1097\/CCM.0b013e3182416f23.","journal-title":"Crit Care Med"},{"key":"6821_CR49","doi-asserted-by":"publisher","unstructured":"A tool for the potential fall 2009 wave of pandemic H1N1 to guide public health decision-making: An overview of the Public Health Agency of Canada\u2019s planning considerations, September 2009. Can Commun Dis Rep. 2010; 36(Suppl 3): 1\u201320. https:\/\/doi.org\/10.14745\/ccdr.v36i00as3.","DOI":"10.14745\/ccdr.v36i00as3"},{"issue":"1","key":"6821_CR50","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1155\/2006\/862797","volume":"13","author":"G Zahariadis","year":"2006","unstructured":"Zahariadis G, Gooley TA, Ryall P, et al. Risk of ruling out severe acute respiratory syndrome by ruling in another diagnosis: variable incidence of atypical bacteria coinfection based on diagnostic assays. Can Respir J. 2006;13(1):17\u201322. https:\/\/doi.org\/10.1155\/2006\/862797.","journal-title":"Can Respir J"},{"issue":"8","key":"6821_CR51","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3109\/00365548.2011.570785","volume":"43","author":"N Johansson","year":"2011","unstructured":"Johansson N, Kalin M, Hedlund J. Clinical impact of combined viral and bacterial infection in patients with community-acquired pneumonia. Scand J Infect Dis. 2011;43(8):609\u201315. https:\/\/doi.org\/10.3109\/00365548.2011.570785.","journal-title":"Scand J Infect Dis"},{"issue":"4","key":"6821_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018928","volume":"6","author":"PGM Bezerra","year":"2011","unstructured":"Bezerra PGM, Britto MCA, Correia JB, et al. Viral and atypical bacterial detection in acute respiratory infection in children under five years. PLoS ONE. 2011;6(4): e18928. https:\/\/doi.org\/10.1371\/journal.pone.0018928.","journal-title":"PLoS ONE"},{"issue":"50","key":"6821_CR53","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002332","volume":"94","author":"MP Crotty","year":"2015","unstructured":"Crotty MP, Meyers S, Hampton N, et al. Epidemiology, co-infections, and outcomes of viral pneumonia in adults: an observational cohort study. Medicine (Baltimore). 2015;94(50): e2332. https:\/\/doi.org\/10.1097\/MD.0000000000002332.","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"6821_CR54","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","volume":"8","author":"X Yang","year":"2020","unstructured":"Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475\u201381. https:\/\/doi.org\/10.1016\/S2213-2600(20)30079-5.","journal-title":"Lancet Respir Med"},{"issue":"10223","key":"6821_CR55","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5.","journal-title":"China Lancet"},{"issue":"10223","key":"6821_CR56","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507\u201313. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7.","journal-title":"Lancet"},{"issue":"8","key":"6821_CR57","doi-asserted-by":"publisher","first-page":"2000170","DOI":"10.2807\/1560-7917.ES.2020.25.8.2000170","volume":"25","author":"L Bordi","year":"2020","unstructured":"Bordi L, Nicastri E, Scorzolini L, et al. Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS-CoV-2), Italy, February 2020. Euro Surveill. 2020;25(8):2000170. https:\/\/doi.org\/10.2807\/1560-7917.ES.2020.25.8.2000170.","journal-title":"Euro Surveill"},{"key":"6821_CR58","unstructured":"World Health Organization. Clinical management of COVID-19 interim guidance [Internet].Geneva, Switzerland: WorldHealthOrganization; 2020. https:\/\/www.who.int\/publications-detail\/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected."},{"issue":"5","key":"6821_CR59","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1007\/s00134-020-06022-5","volume":"46","author":"W Alhazzani","year":"2020","unstructured":"Alhazzani W, M\u00f8ller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):854\u201387. https:\/\/doi.org\/10.1007\/s00134-020-06022-5.","journal-title":"Intensive Care Med"},{"issue":"4","key":"6821_CR60","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","volume":"20","author":"H Shi","year":"2020","unstructured":"Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020;20(4):425\u201334. https:\/\/doi.org\/10.1016\/S1473-3099(20)30086-4.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"6821_CR61","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/irv.12398","volume":"10","author":"EY Klein","year":"2016","unstructured":"Klein EY, Monteforte B, Gupta A, et al. The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respir Viruses. 2016;10(5):394\u2013403. https:\/\/doi.org\/10.1111\/irv.12398.","journal-title":"Influenza Other Respir Viruses"},{"issue":"2","key":"6821_CR62","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/1568005043340920","volume":"4","author":"S Richter","year":"2004","unstructured":"Richter S, Parolin C, Palumbo M, et al. Antiviral properties of quinolone-based drugs. Curr Drug Targets Infect Disord. 2004;4(2):111\u20136. https:\/\/doi.org\/10.2174\/1568005043340920.","journal-title":"Curr Drug Targets Infect Disord"},{"key":"6821_CR63","doi-asserted-by":"publisher","unstructured":"Marciniec K, Beberok A, Boryczka S, et al. Ciprofloxacin and moxifloxacin could interact with SARS-CoV-2 protease: preliminary in silico analysis (3\/23\/2020). https:\/\/doi.org\/10.2139\/ssrn.3562475.","DOI":"10.2139\/ssrn.3562475"},{"key":"6821_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.07.041","author":"C Garcia-Vidal","year":"2020","unstructured":"Garcia-Vidal C, Sanjuan G, Moreno-Garcia E, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2020. https:\/\/doi.org\/10.1016\/j.cmi.2020.07.041.","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"6821_CR65","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727\u201333. https:\/\/doi.org\/10.1056\/NEJMoa2001017.","journal-title":"N Engl J Med"},{"issue":"6","key":"6821_CR66","doi-asserted-by":"publisher","first-page":"2000562","DOI":"10.1183\/13993003.00562-2020","volume":"55","author":"WH Liang","year":"2020","unstructured":"Liang WH, Guan WJ, Li CC, et al. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China. Eur Respir J. 2020;55(6):2000562. https:\/\/doi.org\/10.1183\/13993003.00562-2020.","journal-title":"Eur Respir J"},{"key":"6821_CR67","unstructured":"Randomised Evaluation of COVID-19 Therapy (RECOVERY Trial). Principal investigator: Peter W Horby. University of Oxford. ClinicalTrials.gov number NCT04381936; ISR number 50189673."},{"issue":"1","key":"6821_CR68","doi-asserted-by":"publisher","first-page":"13093","DOI":"10.1038\/s41598-020-70143-6","volume":"10","author":"F Touret","year":"2020","unstructured":"Touret F, Gilles M, Barral K, et al. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. Sci Rep. 2020;10(1):13093. https:\/\/doi.org\/10.1038\/s41598-020-70143-6.","journal-title":"Sci Rep"},{"issue":"1","key":"6821_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105949","volume":"56","author":"P Gautret","year":"2020","unstructured":"Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56(1): 105949. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105949.","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"6821_CR70","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012560","volume":"12","author":"JA Bengoechea","year":"2020","unstructured":"Bengoechea JA, Bamford CG. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19? EMBO Mol Med. 2020;12(7): e12560. https:\/\/doi.org\/10.15252\/emmm.202012560.","journal-title":"EMBO Mol Med"},{"key":"6821_CR71","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1772110","author":"MA Hendaus","year":"2020","unstructured":"Hendaus MA, Jomha FA. Covid-19 induced superimposed bacterial infection. J Biomol Struct Dyn. 2020. https:\/\/doi.org\/10.1080\/07391102.2020.1772110.","journal-title":"J Biomol Struct Dyn"},{"issue":"7","key":"6821_CR72","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1093\/jac\/dkaa194","volume":"75","author":"TM Rawson","year":"2020","unstructured":"Rawson TM, Moore LSP, Castro-Sanchez E, et al. COVID-19 and the potential long-term impact on antimicrobial resistance. J Antimicrob Chemother. 2020;75(7):1681\u20134. https:\/\/doi.org\/10.1093\/jac\/dkaa194.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"6821_CR73","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1473-3099(17)30724-7","volume":"18","author":"M Sharland","year":"2018","unstructured":"Sharland M, Pulcini C, Harbarth S, et al. Classifying antibiotics in the WHO essential medicines list for optimal use-be AWaRe. Lancet Infect Dis. 2018;18(1):18\u201320. https:\/\/doi.org\/10.1016\/S1473-3099(17)30724-7.","journal-title":"Lancet Infect Dis"},{"key":"6821_CR74","doi-asserted-by":"publisher","DOI":"10.1128\/jmbe.v22i1.2285","author":"BS Mayi","year":"2021","unstructured":"Mayi BS, Mainville M, Altaf R, Lanspa M, Vaniawala S, Ollerhead TA, Raja A. A crucial role for antimicrobial stewardship in the midst of COVID-19. J Microbiol Biol Educ. 2021. https:\/\/doi.org\/10.1128\/jmbe.v22i1.2285.","journal-title":"J Microbiol Biol Educ."},{"issue":"14","key":"6821_CR75","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.2147\/IDR.S305349","volume":"28","author":"K Sehgal","year":"2021","unstructured":"Sehgal K, Fadel HJ, Tande AJ, Pardi DS, Khanna S. Outcomes in patients with SARS-CoV-2 and Clostridioides difficile coinfection. Infect Drug Resist. 2021;28(14):1645\u20138. https:\/\/doi.org\/10.2147\/IDR.S305349.","journal-title":"Infect Drug Resist"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06821-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06821-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06821-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T18:10:07Z","timestamp":1673719807000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06821-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6821"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06821-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,8]]},"assertion":[{"value":"15 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was also carried out in accordance with the Declaration of Helsinki and was approved by the Institutional Research Ethics Committee of M\u00e1laga on March 27, 2020 (Ethics Committe code: SEMI-COVID-19 27-03-20), as per the guidelines of the Spanish Agency of Medicines and Medical Products. Informed consent was obtained from all participants for using of their medical data for all research derived from the SEMI-COVID-19 registry. Data confidentiality and patient anonymity were maintained at all times, in accordance with Spanish regulations on observational studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval\u00a0and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors hereby declare they have no conflict of interest related to this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1144"}}